Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Aurora Spine Receives FDA 510(k) Clearance For Pre-Packaged Sterile ZIP 51 MIS Interspinous Fixation Implant

November 17, 2014 – 5:00 pm | Edit Post

Aurora Spine Receives FDA 510(k) Clearance for Pre-Packaged Sterile ZIP 51(TM) MIS Interspinous Fixation ImplantCARLSBAD, CALIFORNIA–(Marketwired – Nov 18, 2014) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZIP 51, Aurora Spine’s slimmest minimally invasive…

Organovo Announces Commercial Release Of The exVive3D??? Human Liver Tissue

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 18, 2014 /PRNewswire/ — Organovo Holdings, Inc. (NYSE MKT: ONVO) (“Organovo”), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced the full commercial release of the exVive3DTM Human Liver Tissue for preclinical drug discovery…

Aurora Spine Receives FDA 510(k) Clearance For Pre-Packaged Sterile ZIP 51 MIS Interspinous Fixation Implant

November 17, 2014 – 5:00 pm | Edit Post

Aurora Spine Receives FDA 510(k) Clearance for Pre-Packaged Sterile ZIP 51(TM) MIS Interspinous Fixation ImplantCARLSBAD, CALIFORNIA–(Marketwired – Nov 18, 2014) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ZIP 51, Aurora Spine’s slimmest minimally invasive…

Safety And Feasibility Of Cytori Therapeutics, Inc. Cell Therapy In Acute Myocardial Infarction Presented At 2014 American Heart Association Meeting

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Data was presented at the American Heart Association meeting in Chicago on November 17, 2014 regarding the safety and feasibility of Cytori Cell Therapy using Adipose Derived Regenerative Cells (ADRCs) administered through the coronary artery in patients with acute ST segment elevated myocardial infarction from the ADVANCE clinical trial sponsored by Cytori Therapeutics…

bioM??rieux And Illumina, Inc. Enter Agreement To Co-Develop A Next-Generation Sequencing Solution For Epidemiological Monitoring Of Bacterial Infections

November 17, 2014 – 5:00 pm | Edit Post

bioMrieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial InfectionsMARCY LETOILE, France & SAN DIEGO–(BUSINESS WIRE)–bioMrieux, a world leader in the field of in vitro diagnostics, and Illumina (ILMN), a world leader in genomics, announced they have signed an exclusive…

bioM??rieux And Illumina, Inc. Enter Agreement To Co-Develop A Next-Generation Sequencing Solution For Epidemiological Monitoring Of Bacterial Infections

November 17, 2014 – 5:00 pm | Edit Post

bioMrieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial InfectionsMARCY LETOILE, France & SAN DIEGO–(BUSINESS WIRE)–bioMrieux, a world leader in the field of in vitro diagnostics, and Illumina (ILMN), a world leader in genomics, announced they have signed an exclusive…

Polaris Group Announces Treatment Of First Patient In Phase 1 Study Of ADI-PEG 20 Plus Doxorubicin In HER2 Negative Breast Cancer

November 17, 2014 – 5:00 pm | Edit Post

SAN DIEGO, Nov. 18, 2014 /PRNewswire/ — Polaris Group announced today that the first patient has been dosed in its Phase 1 trial of ADI-PEG 20 in combination with doxorubicin for the treatment of HER2 negative metastatic breast cancer. Polaris Group is currently conducting clinical trials on ADI-PEG 20 in combination…

New Study Shows How ZMapp Binds to Ebola, Ways to Boost Potency

November 17, 2014 – 2:18 pm | Edit Post

Scientists at The Scripps Research Institute have produced the first 3-D image of how the ZMapp drug developed by San Diego’s Mapp Biopharmaceutical binds to the Ebola virus, providing new insights…
[[Click headline to continue reading.]]

Anti-Leukemia Drug May Also Work Against Ovarian Cancer

November 17, 2014 – 1:00 pm | Edit Post

An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well, report researchers at the University of California, San Diego School of Medicine.

The Dirty Side of Soap

November 17, 2014 – 1:00 pm | Edit Post

Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical.